This lack of correlation is in line with the fact that some beneficial effects of thiazolidinediones on inflammation or atherosclerosis markers have been shown to be independent from blood glucose control and attributed to PPAR-γ [38]. The gene discussed is PPARG; the disease is atherosclerosis.